Articles By This Author

Aljazeera America – Jobs – Apple vs. Samsung

http://youtu.be/uorYwtGDuPI David talks to Aljazeera host Morgan Kelly Radford on a range of issues including Jobs and the low labor participation rate. Morgan turns the tables and moves on to the battle between Apple & Samsung. David says this is Steve Job’s Holy War against Google.

Read More

The Willis Report – Buffett – Obamacare – Jobs

http://youtu.be/sLvPCaPhr6M I was fired up. I don’t often get to talk that much and last night I couldn’t turn it off. We covered a lot of topics. Jobs, Buffett, Obamacare and more. Tracy Burns filling in for Gerri Willis was awesome.

Read More

Climbing the Wall – April 2014 Alpha Select Update

Alpha Select – April 2014 Update *Alpha Select – MTD (-0.11%) YTD +2.80% **S&P 500 – MTD +0.62% YTD +2.53% * Net of Fees ** Includes Dividends By David Nelson After starting off the month with a push to all-time highs markets quickly headed south and by mid-month were down close to 4%. Even confirmed […]

Read More

Toyota’s move to Texas from California is just the beginning

David is interviewed by the Street’s Debra Borchardt and shares his views on Toyota’s recent decision to move their U.S. headquarters from California to Texas. “It’s all about money.”

Read More

CNBC – GILD Beats & AMGN Misses – David from the floor of the NYSE

http://youtu.be/18LEC6M-_1U David reacts to GILD and AMGN earnings from the floor of the exchange on CNBC’s Closing Bell

Read More

The C-Suite Conspiracy

By David Nelson Income inequality and the widening gap between the rich and poor has become a central theme that will likely dominate the political landscape as we head into the mid-term elections. Both sides of the aisle frame the debate differently and as you might expect there is a lot of finger pointing when […]

Read More

The Heartbleed Bug – How Serious Is It? – Fox News Interview

http://youtu.be/EAeSMlAerqw David talks to Fox News host Arthel Neville about the Heart Bleed Bug and what the public should know.

Read More

Gilead’s (GILD) $1000 Pill

By David Nelson, CFA Gilead (GILD) was ground zero for the Biotech sell-off. The sector is down about 25% from its highs made earlier in the year and now (GILD) may be where the sector makes its stand. Unlike Amazon (AMZN), Netflix (NFLX), Tesla (TSLA) and others that have been hit hard by the recent […]

Read More

.